Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
International Journal of STD & AIDS|February 27, 2013
Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMISE Arathoon, S Schneider, E Baraldi, et al.
HIV Clinical Trials|September 3, 2009
Cost-effectiveness of raltegravir in antiretroviral treatment-experienced HIV-1-infected patients in SwitzerlandE E Elbasha, T Szucs, M A Chaudhary, et al.
AIDS (London, England)|March 15, 1997
Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavirL R Bisset, M Rothen, H I Joller-Jemelka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1993
Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidineA U Teuscher, M Opravil, R Theiler, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
Shortcomings of chest radiography in detecting Pneumocystis carinii pneumoniaM Opravil, B Marincek, W A Fuchs, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1997
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort StudyM Opravil, M Pechère, R Speich, et al.
Klinische Wochenschrift|May 24, 1991
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcomaR Baumann, M G Täuber, M Opravil, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDSB Hirschel, P Chopard, J P Chave, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
AIDS (London, England)|December 2, 1998
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort StudyL R Bisset, R W Cone, W Huber, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
International Journal of STD & AIDS|February 27, 2013
Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMISE Arathoon, S Schneider, E Baraldi, et al.
HIV Clinical Trials|September 3, 2009
Cost-effectiveness of raltegravir in antiretroviral treatment-experienced HIV-1-infected patients in SwitzerlandE E Elbasha, T Szucs, M A Chaudhary, et al.
AIDS (London, England)|March 15, 1997
Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavirL R Bisset, M Rothen, H I Joller-Jemelka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1993
Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidineA U Teuscher, M Opravil, R Theiler, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
Shortcomings of chest radiography in detecting Pneumocystis carinii pneumoniaM Opravil, B Marincek, W A Fuchs, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1997
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort StudyM Opravil, M Pechère, R Speich, et al.
Klinische Wochenschrift|May 24, 1991
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcomaR Baumann, M G Täuber, M Opravil, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDSB Hirschel, P Chopard, J P Chave, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
AIDS (London, England)|December 2, 1998
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort StudyL R Bisset, R W Cone, W Huber, et al.
Pageof 12